(Total Views: 109)
Posted On: 10/04/2021 8:20:50 AM
Post# of 224617

$TOMDF News Article - Todos Medical Provides Update on COVID-19 Oral Antiviral 3CL Protease (Main Protease) Inhibitor Tollovir Clinical Development Program in Light of Molnupiravir Clinical Trial Data from Merck https://marketwirenews.com/news-releases/todo...20369.html


My Twitter: WhyteStocks